ATANIS Biotech AG

📍 Bern, Switzerland🗓 Founded 2021👥 26 employees💰 Last funded Aug 2024
Biotechnology🌐 atanis-biotech.com
Website LinkedIn
ATANIS Biotech AG has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test is used to assess safety and efficacy of potential new drug candidates for allergy treatment. It is being developed for an upcoming commercialization in the clinic. Contact us at: info@atanis-biotech.com
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in ATANIS Biotech AG?
ATANIS Biotech AG has 1 investors on record on gritt.io, 1 mid-stage.
When did ATANIS Biotech AG last raise funding?
The most recent investment in ATANIS Biotech AG recorded on gritt.io was in August 2024.
When was ATANIS Biotech AG founded?
ATANIS Biotech AG was founded in 2021.
What industry is ATANIS Biotech AG in?
ATANIS Biotech AG operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ATANIS Biotech AG based?
ATANIS Biotech AG is headquartered in Bern, Switzerland.